Cubist Systematic Strategies’s Longevity Health Holdings, Inc. Common Stock XAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-422
Closed -$130K 4039
2023
Q2
$130K Sell
422
-300
-42% -$91.9K ﹤0.01% 2934
2023
Q1
$220K Sell
722
-192
-21% -$57.9K ﹤0.01% 3180
2022
Q4
$272K Sell
914
-160
-15% -$47.2K ﹤0.01% 3417
2022
Q3
$314K Buy
1,074
+544
+103% +$159K ﹤0.01% 3488
2022
Q2
$154K Buy
+530
New +$154K ﹤0.01% 3805

Other funds holding XAGE

Cubist Systematic Strategies's XAGE Position: Q3 2023 in Review

Cubist Systematic Strategies sold out of Longevity Health Holdings, Inc. Common Stock (XAGE) in Q3 2023, closing a stake of 422 shares — an estimated $130K sold.

Cubist Systematic Strategies first reported a position in XAGE in Q2 2022 and held it in 5 quarters. The position peaked at $314K in Q3 2022. 14 funds tracked by Wall St. Rank hold XAGE as of Q3 2023.

  • Cubist Systematic Strategies reported no remaining Longevity Health Holdings, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Cubist Systematic Strategies sold 422 Longevity Health Holdings, Inc. Common Stock shares in Q3 2023, an estimated $130K.
  • Cubist Systematic Strategies first reported a position in Longevity Health Holdings, Inc. Common Stock in Q2 2022 and held it in 5 quarters.
  • Cubist Systematic Strategies's Longevity Health Holdings, Inc. Common Stock position peaked at $314K in Q3 2022.
  • 14 funds tracked by Wall St. Rank held Longevity Health Holdings, Inc. Common Stock as of Q3 2023.

Based on Cubist Systematic Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.